TEDMED2012: Dr. Ben Goldacre: What doctors don't know about the drugs they prescribe
Evan Sisson, PharmD, Q3: What LDL Level Should Patients Aim For?
Evan Sisson, PharmD, MHA, CDE, assistant professor at the Virginia...
Cecilia Sauter, CDE, Q1: Training Medical Practitioners in Diabetes Education
Cecilia Sauter talks about how she teaches diabetes professionals to...
Cecilia Sauter, CDE, Q4: Case Study - How to Approach Patients with Specific Ethnic Food Preferences
Cecilia Sauter answers Steve Freed's case study question regarding...
Evan Sisson, PharmD, MHA, CDE, Introduction
Evan Sisson gives us a brief introduction of himself and the work that...
Evan Sisson, PharmD, Q1: What Are the Current Guidelines on Lipid Treatment?
Evan Sisson, PharmD, MHA, CDE, explains that the most recent guidelines on...
Evan Sisson, PharmD, Q2: How Has the Definition of the "Right" Level for LDL Changed?
Evan Sisson discusses how researchers are getting closer to an...
Evan Sisson, PharmD, Q4: What Is the Best LDL?
Evan Sisson answers the question: If you could have any LDL you...
Evan Sisson, PharmD, Q5: Should We Just Add Statins to Our Drinking Water?
Evan Sisson talks about past concerns around statin risk and notes...
Evan Sisson, PharmD, Q6: What Kinds of New Drugs Are in the Pipeline?
Evan Sisson, notes that, even in the recent past, drug therapy was...
Evan Sisson, PharmD, Q7: How Can Lifestyle Affect Statin Use?
Evan Sisson talks about how the foundation of his approach to treating...
Dr. Gregory Frost Introduction
Dr. Frost introduces himself to us and talks about Halozyme, and how...
Dr. Gregory Frost Q1 What Is Halozyme's Current Focus?
Dr. Frost talks about the background and history of Halozyme's...
Dr. Gregory Frost Q2 Who Participated in the Study and How Did They Do?
Dr. Frost goes over some of the details of the Halozyme study...
Dr. Gregory Frost Q3 Possible Breakthrough with an Insulin Additive
Dr. Frost talks about the results of the Halozyme study and the...
Dr. Carol Wysham, Q4 Issues with Patients on Nutrition and Fitness Medicine
Dr. Wysham discusses the most difficult challenges in managing...
Stanley Schwartz, MD, Q4: What Is the Best A1c?
Dr. Schwartz discusses what the best A1c might be for a patient...
Stanley Schwartz, MD, Q3: How Exercise Fits In with Diabetes Control
Dr. Schwartz talks about how most patients just can't do enough...
Stanley Schwartz, MD, Q2: Tips for Maximizing Medication Effectiveness and Patient Health
Dr. Schwartz talks about what works best (keeping it simple is very...
Stanley Schwartz, MD: Preventing Hypoglycemia in the Hospital Using Incretins
Dr. Schwartz describes how he helped to develop an intensive insulin...
Stanley Schwartz, MD, Introduction
Dr. Schwartz introduces himself and talks about his busy...
Aaron I. Vinik, MD, PhD, FCP, MACP, Q4 Thoughts on GLP-1
Dr. Vinik explains exactly how GLP-1's work and also discusses his...
Aaron I. Vinik, MD, PhD, FCP, MACP, Q3 Thoughts on Metformin
Dr. Vinik talks about the use of metformin and the problems of B12...
Aaron I. Vinik, MD, PhD, FCP, MACP, Q2 Potential Risks of Intensive Therapy
Aaron I. Vinik, MD, PhD, FCP, MACP, talks about when the...
James R. Thrasher, MD, Q5: What Do You Want Your A1c to Be?
Dr. Thrasher lets us know what his A1c is, and why just having one...
James R. Thrasher, MD, Q4 Difficulties with Getting Patients to Exercise
Dr. Thrasher outlines the difficulties of getting patients to...
James R. Thrasher, MD, Q3 What Do You Do to Help Your Patients with Type 2 Diabetes?
Dr. Thrasher emphasizes the importance of spending time counseling...
James R. Thrasher, MD, Q2 Patient Type for DPP-4
Dr. Thrasher discusses the recent ADA and AACE guidelines for...
James R. Thrasher, MD: Education, Nutrition, Physical Activity
Dr. Thrasher discusses the nutrition and education...
James R. Thrasher, MD, Introduction
Dr. Thrasher introduces himself, and describes his recent research...
Philip E. Cryer, MD: Hypoglycemia in the Absence of Diabetes
Dr. Cryer explains how hypoglycemia shows up in the non-diabetic...
Dr. Carol Wysham, Q2 SGLT2 Differences
Dr. Wysham goes over the details of how the new SGLT2 compounds...
Dr. Carol Wysham, Q1 Expectations of the 2012 ADA meeting
Dr. Wysham tells us about her anticipation of the results of two...
